Access cutting-edge birth asphyxia treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Orange location
Access birth asphyxia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related birth asphyxia treatment provided free
Check if you qualify for this birth asphyxia clinical trial in Orange, CA
No-Cost Study Care
Local to Orange
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Hypoxic-ischemic encephalopathy (HIE) affects approximately 4,000 to 12,000 persons annually in the United States. Mortality from HIE has been reported up to 60%, with at least 25% of survivors left with significant neurocognitive disability. Despite this vital unmet medical need, no pharmacological adjunct or alternative therapy has proven beneficial in improving outcomes in neonatal HIE. RLS-0071 is a novel peptide being developed for the treatment of neonatal HIE. This study is designed to e
Sponsor: ReAlta Life Sciences, Inc.
Yes, this clinical trial (NCT05778188) has an active research site in Orange, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for birth asphyxia treatment options in Orange, CA, this clinical trial (NCT05778188) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced birth asphyxia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all birth asphyxia clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in Orange — not just this study.
Browse Ankylosing Spondylitis Trials in Orange →